Kamunting Street Capital Management, L.P. Coherus Bio Sciences, Inc. Transaction History

Kamunting Street Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $291,750 - $563,250	-25,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $408,249 - $534,250	25,000 New	25,000 $450,000
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $196,500 - $331,500	-15,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $125,700 - $232,500	15,000 New	15,000 $205,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $85.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.